Leerink Partners Maintains Market Perform on Progyny, Lowers Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners has maintained a Market Perform rating on Progyny (NASDAQ:PGNY) but lowered its price target from $25 to $21, indicating a more cautious outlook.
September 19, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Leerink Partners has maintained a Market Perform rating on Progyny but lowered the price target from $25 to $21, suggesting a more cautious outlook on the stock.
The lowering of the price target from $25 to $21 by Leerink Partners indicates a less optimistic view on Progyny's future performance, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100